418 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
AZN Astrazeneca PLC $37.56 $95.16B Downtrend
Article Searches
Why the Earnings Surprise Streak Could Continue for Astrazeneca (AZN) http://www.zacks.com/stock/news/345569/why-the-earnings-surprise-streak-could-continue-for-astrazeneca-azn?cid=CS-ZC-FT-345569 Jan 03, 2019 - Astrazeneca (AZN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Immunomedics Enters Into Supply Deal for Breast Cancer Drug http://www.zacks.com/stock/news/344853/immunomedics-enters-into-supply-deal-for-breast-cancer-drug?cid=CS-ZC-FT-344853 Dec 27, 2018 - Immunomedics (IMMU) entered into a long-term master supply agreement for lead candidate, sacituzumab govitecan.
Forget J&J, Buy These 3 Big Drug Stocks Instead in 2019 http://www.zacks.com/stock/news/344663/forget-jj-buy-these-3-big-drug-stocks-instead-in-2019?cid=CS-ZC-FT-344663 Dec 27, 2018 - J&J's (JNJ) stock has declined more than 14% since Reuters reported that it knew for decades that its baby powders contained asbestos. It is better to avoid the stock and invest in these three big drug stocks instead.
Top Research Reports for Procter & Gamble, Oracle & United Parcel Service http://www.zacks.com/research-daily/199421/top-research-reports-for-procter-gamble-oracle-united-parcel-service?cid=CS-ZC-FT-199421 Dec 21, 2018 - Top Research Reports for Procter & Gamble, Oracle & United Parcel Service
Pharma Stock Roundup: GSK, PFE Ink Consumer Health JV, JNJ Hit by Talc Allegations http://www.zacks.com/stock/news/344133/pharma-stock-roundup-gsk-pfe-ink-consumer-health-jv-jnj-hit-by-talc-allegations?cid=CS-ZC-FT-344133 Dec 21, 2018 - Glaxo (GSK) and Pfizer (PFE) agree to merge their consumer healthcare units into a new JV. J&J stock hit by reports alleging it of being aware of the presence of asbestos in baby powder.
Myriad Genetics' New FDA Nod for BRACAnalysis CDx Widens Base http://www.zacks.com/stock/news/343873/myriad-genetics-new-fda-nod-for-bracanalysis-cdx-widens-base?cid=CS-ZC-FT-343873 Dec 20, 2018 - Myriad Genetics (MYGN) progresses well with initiatives to boost the uptake of the BRACAnalysis CDx test. The recent approval to increase the customer base is an added positive.
BMY vs. AZN: Which Stock Should Value Investors Buy Now? http://www.zacks.com/stock/news/343451/bmy-vs-azn-which-stock-should-value-investors-buy-now?cid=CS-ZC--343451 Dec 18, 2018 - BMY vs. AZN: Which Stock Is the Better Value Option?
Merck to Acquire Europe's Antelliq Group for $2.4 Billion http://www.zacks.com/stock/news/343304/merck-to-acquire-europes-antelliq-group-for-%2424-billion?cid=CS-ZC-FT-343304 Dec 17, 2018 - Merck (MRK) secures an acquisition deal to purchase French animal health company Antelliq Group for a consideration of around $2.4 billion.
Stock Market Power Rankings: Down Is the New Up https://www.fool.com/investing/2018/12/16/stock-market-power-rankings-down-is-the-new-up.aspx?source=iedfolrf0000001 Dec 16, 2018 - They're big, beautiful, and ranked from 1 to 50.
Pharma Stock Roundup: AZN, RHHBY Cancer Drugs, LLY, BMY New Deals in Focus http://www.zacks.com/stock/news/342950/pharma-stock-roundup-azn-rhhby-cancer-drugs-lly-bmy-new-deals-in-focus?cid=CS-ZC-FT-342950 Dec 14, 2018 - AstraZeneca's (AZN) Imfinzi misses endpoint in study. Roche's (RHHBY) cancer drug combo gets FDA nod for first-line lung cancer. Lilly (LLY) & Bristol Myers (BMY) sign new deals.

Pages: 1234567891011...42

<<<Page 6>